Atracare uses DNA testing as part of psych evaluation
Atracare recently announced the use of GeneSight DNA Testing as a part of its psychiatric evaluations.
The genetic test analyzes a patient’s DNA to help determine which medications may be most effective for treating their mental health conditions. The test analyzes how a patient’s genes may affect their body’s ability to metabolize and respond to specific medications commonly used to treat depression, anxiety and other mental health conditions.
The GeneSight test analyzes a patient’s DNA using a simple cheek swab and does not require a needle. The test looks at variations in genes that affect how the patient’s body processes certain medications. Test results are used to create a personalized medication plan for the patient, which helps doctors choose the most effective medications and dosages based on their genetic profile.
The GeneSight test is especially useful for patients who have not responded well to traditional trial-and-error methods of finding the right medication or those who have experienced unpleasant side effects from their current medication. It can also help reduce the risk of adverse drug reactions or potential drug interactions.
The GeneSight test is a part of Atracare’s initial consultation for patients, adults as well as children, who may be considering medication as part of their mental health plan to help with diagnoses such as depression, anxiety, ADHD and more.
It’s important to note that the GeneSight test is not a diagnostic test and should not be used to diagnose any mental health conditions. Instead, it’s a tool Atracare doctors can use to gain insight and generate quantifiable data on a patient’s personal and unique situation. Atracare will use this data as part of any treatment plan that includes medications, or nutrients such as vitamins or supplements.
Genetics can play a significant role in determining an individual’s response to psychiatric medications. Some people may metabolize drugs more slowly or quickly due to genetic variations, which can affect the drug’s efficacy and potential side effects. Also, genetic factors can influence how an individual’s brain chemistry reacts to specific medications. Understanding a patient’s genetic profile can help doctors tailor their treatment plans to maximize the effectiveness of medication while minimizing adverse effects. Pharmacogenetic testing is a tool used to identify genetic variations that may impact drug metabolism, and can inform medication selection and dosing.
While the test itself is different for everyone, most patients find the testing cost to be around $100. However, Atracare can tell patients exactly how much they would expect to pay, based on their insurance, over the phone at 302-268-8692.
Medicare and Medicaid patients receive this test at no cost to the patient.
To schedule a consultation with the Atracare mental health team, go to atracare.com/services/mental-health.
A full-service medical provider that operates exclusively in Sussex County, Atracare’s walk-in clinics in Ocean View and Lewes are open from 8 a.m. to 8 p.m., daily. To make an appointment, text 302-754-5697 for the Ocean View clinic or 302–517-1385 for Lewes, or go to atracare.com.
